Evidence map›Paper›PMID 25349652›Full record

ReviewWorld journal of cardiology2014

Non-interventional management of resistant hypertension.

Michael Doumas, Costas Tsioufis, Charles Faselis, Antonios Lazaridis, Haris Grassos, Vasilios Papademetriou

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael DoumasMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Costas TsioufisMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Charles FaselisMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Antonios LazaridisMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Haris GrassosMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Vasilios PapademetriouMichael Doumas, Antonios Lazaridis, 2 Propedeutic Department of Internal Medicine, Aristotle University, 54643 Thessaloniki, Greece.
Aristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is one of the most popular fields of research in modern medicine due to its high prevalence and its major impact on cardiovascular risk and consequently on global health. Indeed, about one third of individuals worldwide has hypertension and is under increased long-term risk of myocardial infarction, stroke or cardiovascular death. On the other hand, resistant hypertension, the "uncontrollable" part of arterial hypertension despite appropriate therapy, comprises a much greater menace since long-standing, high levels of blood pressure along with concomitant debilitating entities such as chronic kidney disease and diabetes mellitus create a prominent high cardiovascular risk milieu. However, despite the alarming consequences, resistant hypertension and its effective management still have not received proper scientific attention. Aspects like the exact prevalence and prognosis are yet to be clarified. In an effort to manage patients with resistant hypertension appropriately, clinical doctors are still racking their brains in order to find the best therapeutic algorithm and surmount the substantial difficulties in controlling this clinical entity. This review aims to shed light on the effective management of resistant hypertension and provide practical recommendations for clinicians dealing with such patients.

Indexed as

AdherenceAntihypertensive drugsResistant hypertensionSecondary hypertensionWhite coat hypertension

Identifiers

PMID25349652
PMCPMC4209434
OpenAlexW1969464525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.